2,468 Shares in Intuitive Surgical, Inc. $ISRG Bought by Livforsakringsbolaget Skandia Omsesidigt

Livforsakringsbolaget Skandia Omsesidigt bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,468 shares of the medical equipment provider’s stock, valued at approximately $981,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Laurel Wealth Advisors LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $31,000. Motiv8 Investments LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter worth about $34,000. Main Street Group LTD purchased a new stake in shares of Intuitive Surgical in the first quarter worth about $30,000. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $39,000. Finally, Vermillion Wealth Management Inc. boosted its stake in Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after buying an additional 25 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the subject of several research analyst reports. Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Stifel Nicolaus cut their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a report on Friday, July 17th. Citigroup cut their target price on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a report on Friday, July 17th. Finally, Raymond James Financial restated an “outperform” rating and issued a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Twenty-two research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $508.68.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 72 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total value of $28,303.20. Following the transaction, the director owned 179 shares of the company’s stock, valued at $70,364.90. This represents a 28.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the sale, the director owned 1,245,679 shares in the company, valued at approximately $498,271,600. The trade was a 0.80% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 17,283 shares of company stock valued at $7,015,429. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $372.60 on Friday. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The firm has a market capitalization of $131.63 billion, a P/E ratio of 42.68, a price-to-earnings-growth ratio of 2.69 and a beta of 1.46. The company’s 50-day moving average is $384.60 and its 200 day moving average is $432.76.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter last year, the firm earned $1.81 earnings per share. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. Research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.